Revision as of 10:46, 19 March 2023 edit Baffle gab1978 (talk \| contribs) Extended confirmed users, IP block exemptions, Mass message senders, Pending changes reviewers 95,771 edits m →In media ← Previous edit		Revision as of 13:27, 19 March 2023 edit undo Baffle gab1978 (talk \| contribs) Extended confirmed users, IP block exemptions, Mass message senders, Pending changes reviewers 95,771 edits m per mos Next edit →
Line 19: }} '''Ian Gibbons''' (March 6, ~~1946–May~~1946 – May 23, 2013) was a British [[biochemist]] and [[Molecular biology\|molecular biology researcher]] who served as the [[Chief scientific officer\|chief scientist]] of the US company [[Theranos]], which was founded by [[Elizabeth Holmes]]. For more than 30 years, Gibbons performed research in medical therapeutics and [[diagnostic testing]] prior to joining Theranos in 2005. He attempted to raise issues with Theranos' management about the inaccuracy of their testing devices. In 2013, the night before he was scheduled to be deposed in a lawsuit related to Theranos, Gibbons intentionally overdosed on [[acetaminophen]]; he was hospitalized for several days and died from [[liver failure]]. Theranos collapsed in 2018 after journalist [[John Carreyrou]] revealed in ''[[The Wall Street Journal]]'' its supposedly revolutionary blood testing devices requiring only a [[fingerstick]] of blood had never functioned as claimed. Gibbons had attempted to inform his superiors at Theranos, including Holmes, of the failure of their technology but the company's executives repeatedly ignored his objections.

Ian Gibbons (biochemist): Difference between revisions